Skip to main content
Top
Published in: Heart and Vessels 5/2013

01-09-2013 | Original Article

Inflammatory activation following interruption of long-term cardiac resynchronization therapy

Authors: Andrzej Rubaj, Piotr Ruciński, Krzysztof Oleszczak, Michał K. Trojnar, Maciej Wójcik, Andrzej Wysokiński, Andrzej Kutarski

Published in: Heart and Vessels | Issue 5/2013

Login to get access

Abstract

Previous observations suggest that cardiac resynchronization therapy (CRT) may exert an anti-inflammatory effect. The objective of this study was to evaluate the effect of temporary interruption of long-term CRT on plasma concentrations of proinflammatory cytokines and brain natriuretic peptide (BNP). The study group consisted of 54 patients (32 male and 22 female, mean age 64 years) with chronic heart failure (HF) treated with CRT. BNP, high-sensitivity C-reactive protein (hs-CRP), interleukin 6 (IL-6), and neopterin were measured three times: after 26–28 weeks of continuous CRT (CRT-on), 48 h after its cessation (CRT-off), and 48 h after switching the CRT-on again. CRT interruption resulted in a significant worsening of left ventricular systolic function: reduction of cardiac output (CO), dP/dt, and left ventricular ejection fraction (LVEF), as well as deterioration of mitral regurgitation in the CRT responder group. A significant increase in serum concentrations of hs-CRP, neopterin, IL-6, and BNP was noted in this subpopulation. In CRT nonresponders, no significant changes were observed. In responders the changes in serum concentrations of hs-CRP, IL-6, neopterin, and BNP, following CRT interruption, significantly correlated with the respective changes in thoracic fluid content (TFC) and inversely correlated with LVEF changes. Even short (48 h) interruption of long-term CRT led to a significant increase of proinflammatory cytokines and BNP concentrations in responders. The changes in hs-CRP, IL-6, neopterin, and BNP concentrations correlated with the change in TFC-marker of pulmonary congestion and inversely correlated with the change in LVEF.
Literature
1.
go back to reference McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, Page RL, Hlatky MA, Rowe BH (2007) Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA 297:2502–2514 McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, Page RL, Hlatky MA, Rowe BH (2007) Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA 297:2502–2514
2.
go back to reference Rossi A, Rossi G, Piacenti M, Startari U, Panchetti L, Morales MA (2008) The current role of cardiac resynchronization therapy in reducing mortality and hospitalization in heart failure patients: a meta-analysis from clinical trials. Heart Vessels 23:217–223PubMedCrossRef Rossi A, Rossi G, Piacenti M, Startari U, Panchetti L, Morales MA (2008) The current role of cardiac resynchronization therapy in reducing mortality and hospitalization in heart failure patients: a meta-analysis from clinical trials. Heart Vessels 23:217–223PubMedCrossRef
3.
go back to reference Donal E, Leclercq C, Linde C, Daubert JC (2006) Effects of cardiac resynchronization therapy on disease progression in chronic heart failure. Eur Heart J 27:1018–1025PubMedCrossRef Donal E, Leclercq C, Linde C, Daubert JC (2006) Effects of cardiac resynchronization therapy on disease progression in chronic heart failure. Eur Heart J 27:1018–1025PubMedCrossRef
4.
go back to reference Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 27:1201–1206PubMedCrossRef Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 27:1201–1206PubMedCrossRef
5.
go back to reference Wang Y, Zhou Y, Meng L, Lu X, Ou N, Li X (2009) Inflammatory mediators in Chinese patients with congestive heart failure. J Clin Pharmacol 49:591–599PubMedCrossRef Wang Y, Zhou Y, Meng L, Lu X, Ou N, Li X (2009) Inflammatory mediators in Chinese patients with congestive heart failure. J Clin Pharmacol 49:591–599PubMedCrossRef
6.
go back to reference Seifert M, Schlegl M, Hoersch W, Fleck E, Doelger A, Stockburger M, Butter C (2007) Functional capacity and changes in the neurohormonal and cytokine status after long-term CRT in heart failure patients. Int J Cardiol 121:68–73PubMedCrossRef Seifert M, Schlegl M, Hoersch W, Fleck E, Doelger A, Stockburger M, Butter C (2007) Functional capacity and changes in the neurohormonal and cytokine status after long-term CRT in heart failure patients. Int J Cardiol 121:68–73PubMedCrossRef
7.
go back to reference Lappegard KT, Bjornstad H (2006) Anti-inflammatory effect of cardiac resynchronization therapy. Pacing Clin Electrophysiol 29:753–758PubMedCrossRef Lappegard KT, Bjornstad H (2006) Anti-inflammatory effect of cardiac resynchronization therapy. Pacing Clin Electrophysiol 29:753–758PubMedCrossRef
8.
go back to reference Theodorakis GN, Flevari P, Kroupis C, Adamopoulos S, Livanis EG, Kostopoulou A, Kolokathis F, Paraskevaidis IA, Leftheriotis D, Kremastinos DT (2006) Antiinflammatory effects of cardiac resynchronization therapy in patients with chronic heart failure. Pacing Clin Electrophysiol 29:255–261PubMedCrossRef Theodorakis GN, Flevari P, Kroupis C, Adamopoulos S, Livanis EG, Kostopoulou A, Kolokathis F, Paraskevaidis IA, Leftheriotis D, Kremastinos DT (2006) Antiinflammatory effects of cardiac resynchronization therapy in patients with chronic heart failure. Pacing Clin Electrophysiol 29:255–261PubMedCrossRef
9.
go back to reference Knight BP, Desai A, Coman J, Faddis M, Yong P (2004) Long-term retention of cardiac resynchronization therapy. J Am Coll Cardiol 44:72–77PubMedCrossRef Knight BP, Desai A, Coman J, Faddis M, Yong P (2004) Long-term retention of cardiac resynchronization therapy. J Am Coll Cardiol 44:72–77PubMedCrossRef
10.
go back to reference Fornwalt BK, Sprague WW, BeDell P, Suever JD, Gerritse B, Merlino JD, Fyfe DA, Leon AR, Oshinski JN (2010) Agreement is poor among current criteria used to define response to cardiac resynchronization therapy. Circulation 121:1985–1991PubMedCrossRef Fornwalt BK, Sprague WW, BeDell P, Suever JD, Gerritse B, Merlino JD, Fyfe DA, Leon AR, Oshinski JN (2010) Agreement is poor among current criteria used to define response to cardiac resynchronization therapy. Circulation 121:1985–1991PubMedCrossRef
11.
go back to reference Woltjer HH, Bogaard HJ, de Vries PM (1997) The technique of impedance cardiography. Eur Heart J 18:1396–1403PubMedCrossRef Woltjer HH, Bogaard HJ, de Vries PM (1997) The technique of impedance cardiography. Eur Heart J 18:1396–1403PubMedCrossRef
12.
go back to reference Yu CM, Chau E, Sanderson JE, Fan K, Tang MO, Fung WH, Lin H, Kong SL, Lam YM, Hill MR, Lau CP (2002) Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 105:438–445PubMedCrossRef Yu CM, Chau E, Sanderson JE, Fan K, Tang MO, Fung WH, Lin H, Kong SL, Lam YM, Hill MR, Lau CP (2002) Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 105:438–445PubMedCrossRef
13.
go back to reference Ypenburg C, Lancellotti P, Tops LF, Bleeker GB, Holman ER, Piérard LA, Schalij MJ, Bax JJ (2007) Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol 50:2071–2077PubMedCrossRef Ypenburg C, Lancellotti P, Tops LF, Bleeker GB, Holman ER, Piérard LA, Schalij MJ, Bax JJ (2007) Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol 50:2071–2077PubMedCrossRef
14.
go back to reference Ypenburg C, Van Bommel RJ, Marsan NA, Delgado V, Bleeker GB, van der Wall EE, Schalij MJ, Bax JJ (2008) Effects of interruption of long-term cardiac resynchronization therapy on left ventricular function and dyssynchrony. Am J Cardiol 102:718–721PubMedCrossRef Ypenburg C, Van Bommel RJ, Marsan NA, Delgado V, Bleeker GB, van der Wall EE, Schalij MJ, Bax JJ (2008) Effects of interruption of long-term cardiac resynchronization therapy on left ventricular function and dyssynchrony. Am J Cardiol 102:718–721PubMedCrossRef
15.
go back to reference Kuppahally SS, Fowler MB, Vagelos R, Wang P, Al-Ahmad A, Paloma A, Liang D (2009) Worsening of left ventricular end-systolic volume and mitral regurgitation without increase in left ventricular dyssynchrony on acute interruption of cardiac resynchronization therapy. Echocardiography 26:759–765PubMedCrossRef Kuppahally SS, Fowler MB, Vagelos R, Wang P, Al-Ahmad A, Paloma A, Liang D (2009) Worsening of left ventricular end-systolic volume and mitral regurgitation without increase in left ventricular dyssynchrony on acute interruption of cardiac resynchronization therapy. Echocardiography 26:759–765PubMedCrossRef
16.
go back to reference Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107:1278–1283PubMedCrossRef Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107:1278–1283PubMedCrossRef
17.
go back to reference Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655–663PubMedCrossRef Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655–663PubMedCrossRef
18.
go back to reference Janssen SP, Gayan-Ramirez G, Van den Bergh A, Herijgers P, Maes K, Verbeken E, Decramer M (2005) Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 111:996–1005PubMedCrossRef Janssen SP, Gayan-Ramirez G, Van den Bergh A, Herijgers P, Maes K, Verbeken E, Decramer M (2005) Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 111:996–1005PubMedCrossRef
19.
go back to reference Nakagomi A, Seino Y, Endoh Y, Kusama Y, Atarashi H, Mizuno K (2010) Upregulation of monocyte proinflammatory cytokine production by C-reactive protein is significantly related to ongoing myocardial damage and future cardiac events in patients with chronic heart failure. J Card Fail 16:562–571PubMedCrossRef Nakagomi A, Seino Y, Endoh Y, Kusama Y, Atarashi H, Mizuno K (2010) Upregulation of monocyte proinflammatory cytokine production by C-reactive protein is significantly related to ongoing myocardial damage and future cardiac events in patients with chronic heart failure. J Card Fail 16:562–571PubMedCrossRef
20.
go back to reference Zacho J, Tybjaerg-Hansen A, Nordestgaard BG (2010) C-reactive protein and all-cause mortality—the Copenhagen City Heart Study. Eur Heart J 31:1624–1632PubMedCrossRef Zacho J, Tybjaerg-Hansen A, Nordestgaard BG (2010) C-reactive protein and all-cause mortality—the Copenhagen City Heart Study. Eur Heart J 31:1624–1632PubMedCrossRef
21.
go back to reference Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73–76PubMedCrossRef Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73–76PubMedCrossRef
22.
go back to reference Orus J, Roig E, Perez-Villa F, Pare C, Azqueta M, Filella X, Heras M, Sanz G (2000) Prognostic value of serum cytokines in patients with congestive heart failure. J Heart Lung Transplant 19:419–425PubMedCrossRef Orus J, Roig E, Perez-Villa F, Pare C, Azqueta M, Filella X, Heras M, Sanz G (2000) Prognostic value of serum cytokines in patients with congestive heart failure. J Heart Lung Transplant 19:419–425PubMedCrossRef
23.
go back to reference Suzuki H, Sato R, Sato T, Shoji M, Iso Y, Kondo T, Shibata M, Koba S, Katagiri T (2005) Time-course of changes in the levels of interleukin 6 in acutely decompensated heart failure. Int J Cardiol 100:415–420PubMedCrossRef Suzuki H, Sato R, Sato T, Shoji M, Iso Y, Kondo T, Shibata M, Koba S, Katagiri T (2005) Time-course of changes in the levels of interleukin 6 in acutely decompensated heart failure. Int J Cardiol 100:415–420PubMedCrossRef
24.
go back to reference Jug B, Salobir BG, Vene N, Sebestjen M, Sabovic M, Keber I (2009) Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure. Heart Vessels 24:271–276PubMedCrossRef Jug B, Salobir BG, Vene N, Sebestjen M, Sabovic M, Keber I (2009) Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure. Heart Vessels 24:271–276PubMedCrossRef
25.
go back to reference Trachtenberg BH, Hare JM (2009) Biomarkers of oxidative stress in heart failure. Heart Fail Clin 5:561–577PubMedCrossRef Trachtenberg BH, Hare JM (2009) Biomarkers of oxidative stress in heart failure. Heart Fail Clin 5:561–577PubMedCrossRef
26.
go back to reference Nazer B, Ray KK, Sloan S, Scirica B, Morrow DA, Cannon CP, Braunwald E (2011) Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome. Eur Heart J 32:1390–1397PubMedCrossRef Nazer B, Ray KK, Sloan S, Scirica B, Morrow DA, Cannon CP, Braunwald E (2011) Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome. Eur Heart J 32:1390–1397PubMedCrossRef
27.
28.
go back to reference Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R (2000) Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 87:241–247PubMedCrossRef Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R (2000) Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 87:241–247PubMedCrossRef
29.
go back to reference Streitner F, Kuschyk J, Veltmann C, Ratay D, Schoene N, Streitner I, Brueckmann M, Schumacher B, Borggrefe M, Wolpert C (2009) Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm. Cytokine 47:166–172PubMedCrossRef Streitner F, Kuschyk J, Veltmann C, Ratay D, Schoene N, Streitner I, Brueckmann M, Schumacher B, Borggrefe M, Wolpert C (2009) Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm. Cytokine 47:166–172PubMedCrossRef
30.
go back to reference Ramasubbu K, Oliveira G, Torre-Amione G (2006) Novel therapies for heart failure: focus on anti-inflammatory strategies. Congest Heart Fail 12:153–159PubMed Ramasubbu K, Oliveira G, Torre-Amione G (2006) Novel therapies for heart failure: focus on anti-inflammatory strategies. Congest Heart Fail 12:153–159PubMed
31.
go back to reference Oyama JI, Kudo Y, Maeda T, Node K, Makino N (2012) Hyperthermia by bathing in a hot spring improves cardiovascular functions and reduces the production of inflammatory cytokines in patients with chronic heart failure. Heart Vessels. doi:10.1007/s00380-011-0220-7 Oyama JI, Kudo Y, Maeda T, Node K, Makino N (2012) Hyperthermia by bathing in a hot spring improves cardiovascular functions and reduces the production of inflammatory cytokines in patients with chronic heart failure. Heart Vessels. doi:10.​1007/​s00380-011-0220-7
32.
go back to reference Miettinen KH, Lassus J, Harjola VP, Siirila-Waris K, Melin J, Punnonen KR, Nieminen MS, Laakso M, Peuhkurinen KJ (2008) Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure. Eur J Heart Fail 10:396–403PubMedCrossRef Miettinen KH, Lassus J, Harjola VP, Siirila-Waris K, Melin J, Punnonen KR, Nieminen MS, Laakso M, Peuhkurinen KJ (2008) Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure. Eur J Heart Fail 10:396–403PubMedCrossRef
Metadata
Title
Inflammatory activation following interruption of long-term cardiac resynchronization therapy
Authors
Andrzej Rubaj
Piotr Ruciński
Krzysztof Oleszczak
Michał K. Trojnar
Maciej Wójcik
Andrzej Wysokiński
Andrzej Kutarski
Publication date
01-09-2013
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 5/2013
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-012-0285-y

Other articles of this Issue 5/2013

Heart and Vessels 5/2013 Go to the issue